Zdrowie i gospodarka · 04/11/2010

FDA Requests Public Comment on Proposed Pharmacogenomic Data Collection

The Food and Drug Administration (FDA) is seeking public input on a proposed collection of information related to pharmacogenomic data submissions for drug development, as part of its efforts to streamline the review process.